Denekas Craig N 4
4 · CAMDEN NATIONAL CORP · Filed Jun 3, 2026
Research Summary
AI-generated summary of this filing
Camden National (CAC) Director Craig Denekas Receives 919-Share Award
What Happened Craig N. Denekas, a director of Camden National Corp (CAC), was granted/acquired 919 shares on 2026-06-01 as an award under the company’s equity program. The Form 4 reports the transaction as 919 shares at $0.00 (the filing shows $0.00 because the grant is an award — see footnote). The shares vested immediately on the grant date.
Key Details
- Transaction date: 2026-06-01; Filing date: 2026-06-03 (appears to be filed within the standard two-business-day Form 4 window).
- Reported price: $0.00 in the filing; footnote states price is N/A because these were director equity awards under the Independent Directors' Equity Compensation Program (part of the 2022 Equity and Incentive Plan and Amendment).
- Shares awarded/received: 919; vested immediately on grant.
- Shares owned after transaction: not specified in the summary information provided.
- Transaction code: A (award/grant/acquisition).
Context Director awards like this are typically routine compensation for board service rather than an open-market purchase or sale. Because the award vested immediately and is disclosed as part of the company’s director compensation program, it should be viewed as compensation reporting rather than a direct market-confidence signal.
Insider Transaction Report
- Award
Common Stock
[F1]2026-06-01+919→ 15,999 total
Footnotes (1)
- [F1]Shares granted under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan and Amendment; therefore, price is N/A. These shares vested immediately on the date of the grant.